Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-01

Clinical Trial Update: A Clinical Safety and Efficacy Study in Subjects With Overweight or Obese Class - I, to Evaluate the Degree of Significant Weight Loss by Regular Intake of Phaseolean (White Kidney Bean Standardized Extract) [NA]

View source ↗

Summary

A completed clinical trial evaluating Phaseolean, a white kidney bean standardized extract, for safety and efficacy in achieving significant weight loss in over…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phaseolean (White kidney bean standardized extract (Phaseolus vulgaris extract))

Snippet

Sponsor: NovoBliss Research Pvt Ltd | Conditions: Body Weight in the Overweight and Obese Class - I Population | NA | Status: COMPLETED